MiR-29c inhibits HCV replication<i>via</i>activation of type I IFN response by targeting STAT3 in JFH-1-infected Huh7 cells

Yanjing Wang(Henan University Huaihe Hospital and Huaihe Clinical Institute), Yuanyuan Li(Henan University Huaihe Hospital and Huaihe Clinical Institute)
RSC Advances
January 1, 2018
Cited by 11


Related Papers